Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress plays a significant role in vitiligo, and both skin and non-skin cells may be involved.

Children under 18 had milder SARS with no deaths, but teenagers faced higher severe illness risk, and effective treatments were uncertain.

Improve ventilation and address environmental issues to reduce health complaints.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Alopecia areata treatments often cause headaches and infections, highlighting the need for safer options.

A child on life support experienced rapid hair loss due to severe illness affecting hair growth.

HMPV causes respiratory infections, mainly managed with supportive care, and lacks a vaccine or specific treatment.

Zinc deficiency is linked to respiratory infections in children.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

A woman with Castleman's disease died from respiratory failure due to bronchiolitis obliterans.

People with cleft lip and palate often have respiratory problems.

After moderate COVID-19, cardiovascular patients had fewer respiratory issues but faced new physical and psychological problems.

Recurrent dry cough, wheezing, and respiratory discomfort are key symptoms for diagnosing pediatric asthma.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.